# Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux

> **NCT00414856** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 34 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** AFQ056

## Key facts

- **NCT ID:** NCT00414856
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2007-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00414856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00414856, "Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00414856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*